# A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

> **NCT06288412** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 30 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin icodec
- **DRUG:** Insulin degludec

## Key facts

- **NCT ID:** NCT06288412
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-26
- **Primary completion:** 2025-03-10
- **Final completion:** 2025-04-14
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06288412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06288412, "A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06288412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*